HSBC Holdings
SUPN icon

HSBC Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History

HSBC Holdings’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,129
Closed -$1.23M – 3114
2025
Q2 		$1.23M Sell
39,129
-8,274
-17% -$265K ﹤0.01% 1698
2025
Q1 		$1.54M Sell
47,403
-180,627
-79% -$6.4M ﹤0.01% 1572
2024
Q4 		$8.25M Sell
228,030
-22,334
-9% -$786K ﹤0.01% 990
2024
Q3 		$7.8M Buy
250,364
+236,354
+1,687% +$7.38M ﹤0.01% 978
2024
Q2 		$378K Sell
14,010
-173,394
-93% -$5.03M ﹤0.01% 2141
2024
Q1 		$6.38M Buy
187,404
+177,103
+1,719% +$5.27M ﹤0.01% 1016
2023
Q4 		$297K Sell
10,301
-3,063
-23% -$81.2K ﹤0.01% 2288
2023
Q3 		$369K Sell
13,364
-13,553
-50% -$413K ﹤0.01% 2106
2023
Q2 		$803K Buy
26,917
+6,405
+31% +$224K ﹤0.01% 1797
2023
Q1 		$751K Sell
20,512
-6,818
-25% -$262K ﹤0.01% 1898
2022
Q4 		$973K Buy
27,330
+4,134
+18% +$144K ﹤0.01% 1982
2022
Q3 		$791K Buy
23,196
+5,344
+30% +$174K ﹤0.01% 1941
2022
Q2 		$512K Buy
17,852
+861
+5% +$24.7K ﹤0.01% 2314
2022
Q1 		$550K Buy
+16,991
New +$521K ﹤0.01% 2348
2021
Q3 		– Sell
-7,758
Closed -$241K – 3162
2021
Q2 		$241K Buy
+7,758
New +$238K ﹤0.01% 2655
2020
Q4 		– Sell
-15,111
Closed -$318K – 3141
2020
Q3 		$318K Buy
+15,111
New +$343K ﹤0.01% 2217
2018
Q2 		– Sell
-51,590
Closed -$2.36M – 2698
2018
Q1 		$2.36M Buy
+51,590
New +$2.15M ﹤0.01% 1368
2017
Q1 		– Sell
-8,081
Closed -$204K – 2549
2016
Q4 		$204K Buy
+8,081
New +$181K ﹤0.01% 2519

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's SUPN Position: Q3 2025 in Review

HSBC Holdings sold out of Supernus Pharmaceuticals (SUPN) in Q3 2025, closing a stake of 39,129 shares — an estimated $1.23M sold.

HSBC Holdings first reported a position in SUPN in Q4 2016 and held it in 18 quarters. The position peaked at $8.25M in Q4 2024. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

  • HSBC Holdings reported no remaining Supernus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 39,129 Supernus Pharmaceuticals shares in Q3 2025, an estimated $1.23M.
  • HSBC Holdings first reported a position in Supernus Pharmaceuticals in Q4 2016 and held it in 18 quarters.
  • HSBC Holdings's Supernus Pharmaceuticals position peaked at $8.25M in Q4 2024.
  • 310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.